Daily Stock List
Galaxy Gaming, Inc. (GLXZ)
Marketbeat, RedChip, SmallCapVoice, TaglichBrothers, The Green Baron, FeedBlitz, and Stock Profile reported earlier on Galaxy Gaming, Inc. (GLXZ), and today we highlight the Company, here at the QualityStocks Daily Newsletter.
Galaxy Gaming, Inc. is the world's largest independent developer, manufacturer, and distributor of casino table games and enhanced systems. The Company develops, manufactures, and distributes inventive proprietary table games, state-of-the-art electronic wagering platforms, and enhanced bonusing systems to land-based, riverboat, cruise ships, and online casinos around the world. Galaxy Gaming is based in Las Vegas, Nevada and the Company lists on the OTC Markets Group’s OTCQB.
Galaxy Gaming has an installed base of its products on thousands of gaming tables located in hundreds of casinos. The Company sells its products chiefly through its internal sales force, to casinos throughout North America, the Caribbean, the British Isles, Europe, and Africa, and to cruise ships and internet gaming sites around the world.
Via its iGaming partner, Games Marketing Ltd., Galaxy Gaming licenses its proprietary table games to the online gaming industry. The Company’s games can be played online at FeelTheRush.com.
Furthermore, Galaxy Gaming is expanding its global presence by way of its partnership with WPT Enterprises, Inc. WPT Enterprises is the owner of the World Poker Tour. In addition, Galaxy Gaming is the exclusive provider of SpectrumVision. This is a proprietary technology employed to detect invisible markings on playing cards.
In November of 2016, Galaxy Gaming announced its results for the three and nine months ended September 30, 2016. Financial highlights for Q3 2016 in comparison to Q3 2015 include Revenue of $3,192K - an increase of 16 percent; Adjusted EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) of $1,499K – an increase of 68 percent; Pre-Tax Income of $1,424K - an increase of 569 percent; and Net Income of $821K, an increase of 586 percent.
This past January, Galaxy Gaming announced that Mr. Todd Cravens joined the Company as Vice President of Business Development. Mr. Cravens is responsible for expanding Galaxy Gaming’s business domestically and internationally. The areas of growth targeted includes increasing Galaxy’s core business. Mr. Cravens will also be guiding the Company to provide new leading-edge products and services designed to enhance the business operations of Galaxy Gaming’s casino clients.
Galaxy Gaming, Inc. (GLXZ), closed Tuesday's trading session at $0.635, up 4.10%, on 11,090 volume with 3 trades. The average volume for the last 60 days is 13,860 and the stock's 52-week low/high is $0.181/$0.775.
NuGene International, Inc. (NUGN)
SmallCapVoice reported on NuGene International, Inc. (NUGN), and we also report on the Company, here at the QualityStocks Daily Newsletter.
NuGene International, Inc. specializes in developing, manufacturing, and marketing proprietary regenerative cosmeceutical and pharmaceutical products. These are based on adipose derived human stem cells and human stem cell media. The Company’s aim is to take advantage of its broad knowledge and expertise to develop age defying regenerative cosmeceutical skincare and hair care products, and additionally pharmaceutical products based on the same regenerative science platform. NuGene BioPharma, Inc. is the Company’s subsidiary. OTCQB-listed, NuGene International is based in Irvine, California.
Former supermodel, Ms. Kathy Ireland is Chief Designer, Brand Ambassador, Shareholder & Investor of NuGene International. She has built her business - kathy ireland Worldwide® (kiWW). The foundation of NuGene kathy ireland's cosmeceutical and pharmaceutical products are on proprietary stem cell based regenerative formulations derived from non-controversial, adult human stem cell derived media obtained from adipose tissue.
NuGene kathy ireland's exclusive products combine its in-house advancements, proprietary technologies, as well as patent pending formulations. NuGene’s products include its Skin Care Collection and its Hair Care Collection.
The NuGene BioPharma subsidiary has acquired all rights, title, and interest in and to SkinGuardian®, a Food and Drug Administration (FDA)-approved (monographed) skin protectant, antiseptic, and moisturizing topical cream. It acquired all intellectual property (IP) held by SkinGuardian and its Founder and Owner, Mr. Chris O'Brien, relating to the SkinGuardian technology and applications.
NuGene previously announced the conclusions of an independent clinical study. The independent clinical study concludes that NuGene serum activates multiple anti-aging genes. The study was conducted by Genemarkers LLC (GM), an independent clinical laboratory equipped to analyze gene expression in the human body.
In January 2017, NuGene International announced the targeted launch of its newly reformulated REVELLUS™ Hair Fortifying Serum, designed to help improve the overall vitality of the scalp and promote the appearance of fuller, thicker, and more voluminous hair. REVELLUS™ is formulated with HSCD Proteins, obtained via NuGene International's patent pending adipose derived stem cell culture process, and a strong blend of antioxidants, natural extracts, and peptides.
In February, NuGene International announced it appointed Mr. S. David Ollie as Vice President, Sales. As Vice President of Sales, Mr. Ollie's principal responsibility will be to build a direct U.S. sales force to focus on growing the Company’s sales in the professional aesthetic market. This includes dermatologists, plastic surgeons, aestheticians, and the like. Additionally, he will oversee worldwide distribution of NuGene's branded products and the kathy ireland Worldwide licensed product line. Mr. Ollie will also be developing a network of key opinion leading physicians and a medical advisory board.
NuGene International, Inc. (NUGN), closed Tuesday's trading session at $0.23, up 23.92%, on 76,929 volume with 38 trades. The average volume for the last 60 days is 106,977 and the stock's 52-week low/high is $0.14/$0.875.
Ecosphere Technologies, Inc. (ESPH)
SmallCapVoice, Wall Street Resources, TheMicrocapNews, PennyStocks24, Buzz Stocks, Penny Pick Finders, PennyStockProphet, Planet Penny Stocks, SecretStockPromo, and StockOnion reported earlier on Ecosphere Technologies, Inc. (ESPH), and today we highlight the Company, here at the QualityStocks Daily Newsletter.
Ecosphere Technologies, Inc. is a development and intellectual property (IP) licensing company. It develops environmental solutions for global water, energy, industrial, and agricultural markets. The Company helps industry increase production, reduce costs, and protect the environment via a portfolio of innovative, patented technologies and exclusive and nonexclusive licensing opportunities across a broad array of industries and applications worldwide. Ecosphere Technologies has its headquarters in Stuart, Florida.
The Company has an extensive portfolio of patented clean technologies. These can be purchased and licensed for use in large-scale and sustainable applications across industries, nations, and ecosystems.
Ecosphere’s technologies include the Ecos PowerCube®, the Ecos GrowCube™, and Ozonix®. The Ecosphere technologies and products are available by way of numerous brands and subsidiaries. These include Sea of Green Systems, Ecosphere Development Company, and Fidelity National Environmental Solutions. Ecosphere’s aim is to help clean energy producers’ gain more control over their water resources, quality, and completion costs through providing effective mobile water recycling solutions.
The Ecos PowerCube® is the world’s largest, mobile, solar-powered generator. It runs on high power photovoltaic panels. These panels extend from its container combined with an easy to set up wind turbine. Energy is stored in onboard batteries.
The Ecosphere Ozonix® Technology provides a chemical-free alternative to high-volume water recycling for a diverse range of applications. These range from the oil & natural gas industry and mining to agriculture and municipal wastewater treatment. The oil and natural gas industry is successfully using Ecosphere Technologies’ patented Ozonix® technology to treat and recycle the water used in oil and natural gas well drilling and completion programs.
Additionally, the Company has its Ecos GrowCube®. The Ecos GrowCube® is a state-of-the-art, turn-key, fully-automated "greenhouse". It uses hydroponic growing techniques to maximize the amount of crop production possible in a given footprint. The Ecos GrowCube® incorporates the Company’s patented Ozonix® water treatment technology. Ecosphere also has its Ozonix Sentinel. This is the world's first line of water treatment vessels for cleaning up endangered rivers and lakes.
This past January, Sea of Green Systems (SOGS), a subsidiary of Ecosphere Technologies, announced the launch of its SOGS-650X, Full Spectrum LED Growing Light. This light was developed to provide growers with an engineered solution to maximize vegetative growth and flower production for the indoor agriculture and legal marijuana industries. The SOGS-650X can generate greenhouse-like conditions through providing an average 25 DLI (Daily Light Integral) during the Vegetative and Flowering Cycles, with roughly 450-650 uMols and 700-900 uMols at the plant canopy during their respective growth cycles. Sea of Green Systems (SOGS) sells high-tech growing equipment, lighting solutions, and nutrients to the Precision Agriculture industry.
Recently, Sea of Green Systems (SOGS) announced it completed delivery and installation of 10 DWC100, fully-automated growing systems as well as a water treatment system for its legal, licensed customer in Las Vegas, Nevada.
Designed and manufactured in the United States, each DWC100 provides growers with a 100-plant ready automated system, which produces the highest quality conditions under which medical or food grade plants can be cultivated.
Ecosphere Technologies, Inc. (ESPH), closed Tuesday's trading session at $0.0383, off by 1.54%, on 27,220 volume with 8 trades. The average volume for the last 60 days is 235,174 and the stock's 52-week low/high is $0.02/$0.138.
SmartMetric, Inc. (SMME)
SmallCapFinancialWire, Wall Street Resources, Greenbackers, and Wall St Insider Stocks reported earlier on SmartMetric, Inc. (SMME), and today we report on the Company, here at the QualityStocks Daily Newsletter.
SmartMetric, Inc. is the developer of fingerprint authenticated and activated payments cards for use by credit and debit card issuers internationally. The Company is a technology engineering, research and development (R&D) enterprise. It has developed miniature electronic systems and software for use in the field of biometric identification and validation for the payments industry and also the corporate and government sectors. SmartMetric is based in Las Vegas, Nevada. It has R&D centers in Buenos Aires, Argentina; Palo Alto, California; and Tel-Aviv, Israel. The Company does its hardware and software engineering internally.
SmartMetric has embedded inside a credit card sized identity card a completely functional biometric fingerprint reader. Joining the reader with miniaturized radio frequency technology inside the card provides for a first-class portable biometric identity and access control solution. The Company’s unique miniature fingerprint scanner, which fits inside EMV chip credit cards, will provide an advanced biometric defense to the global payments industry.
SmartMetric, utilizing advanced miniaturization of biometric fingerprint recognition and verification technology, can deliver portable in a card biometrics. Concerning Biometric Payment Security, it brings the strength of biometrics to the domain of payments. One hundred percent identity verification with secure transaction lets the user safely purchase online or offline. The card is useable at ATM machines. The card has the added security of only being able to be used after one has activated it by using their fingerprint. The SmartMetric biometric card scans and matches a person's fingerprint in under 0.25 seconds allowing for instant card user validation.
SmartMetric is developing a biometric activated security code display to fight online card fraud and identity theft. It is developing a credit card that has the card’s security code or “CVV number” activated following the card’s user’s fingerprint match. The SmartMetric biometric fingerprint authentication system works with EMV chip cards, with the EMV chip turned on only after a successful fingerprint scan and match with the card user. It has created a miniature fingerprint reader that is inside the credit and debit card so no other scanning device outside of the card is needed to perform a biometric scan.
SmartMetric’s intention is to market and distribute its multi-function biometric security card through major industry worldwide distributors. It officially launched its pioneering biometric payments card in April 2016. The Company has added an extended battery life feature along with a user fingerprint match indicator to its line of fingerprint biometric activated credit cards and security cards.
SmartMetric has integrated a small square "touch" sensor on its card. It has moved away from using a rectangular "swipe" sensor. The new small touch sensor is easier for the Company to mass manufacture in the card while providing a simple touch and insert function for the consumer. SmartMetric is moving ahead with industry testing and approvals for use of its new biometric credit card.
SmartMetric, Inc. (SMME), closed Tuesday's trading session at $0.0615, up 3.36%, on 223,093 volume with 22 trades. The average volume for the last 60 days is 84,306 and the stock's 52-week low/high is $0.036/$0.1297.
Bearing Resources Ltd. (BRGRF)
We are reporting on Bearing Resources Ltd. (BRGRF) today, here at the QualityStocks Daily Newsletter.
Headquartered in Vancouver, British Columbia, Bearing Resources Ltd. is a mineral exploration and development company. It concentrates mainly on lithium. Via an agreement with Li3 Energy, Inc. (LIEG), Bearing Resources will acquire an undivided 17.7 percent interest in the advanced-stage Maricunga lithium brine project in Chile. This represents one of the highest-grade development opportunities in the Americas. Bearing Resources’ shares trade on the OTC Markets Group’s OTCQB.
Greater than US$30 million has been invested in the Maricunga lithium brine project so far. All future expenditures through to the delivery of a Definitive Feasibility Study (DFS) are fully-funded by its Joint Venture (JV) partners. Bearing Resources is presently centered on identifying, advancing, as well as de-risking lithium projects. The Company carries out all aspects of exploration and development. This is from grassroots prospecting to feasibility studies.
Bearing Resources’ other projects include Fish Lake Valley and the HY/Jay project. The Fish Lake Valley Lithium property is in Esmeralda County, Nevada. It consists of a contiguous 1,620-acre package of 81 lode claims.
The HY/Jay project is in the Upper Hyland River area of eastern Yukon in a belt that hosts a number of high-grade gold vein occurrences. This includes the 3Ace property now undergoing exploration by Golden Predator Mining Corp.
The HY claim group was acquired from Freeport McMoRan Exploration in 2011. Freeport retains a 2-per-cent net smelter royalty (NSR) payable to Freeport, which can be reduced to a 1-per-cent NSR via a one-time payment of $1 million. In 2011, The HY claim group was subsequently expanded by the addition of the Jay claims through staking.
At the beginning of March 2017, Bearing Resources announced it received results from Li3 Energy from the pilot evaporation ponds at the Maricunga lithium brine project. Bearing entered into a definitive agreement to acquire Li3 and its interest in the Maricunga Project. At present, Li3 holds the 17.7 percent interest in the Maricunga Project along with Minera Salar Blanco (MSB) and Lithium Power International Limited at 32.3 percent and 50 percent respectively pursuant to the JV arrangement.
Under the terms of the JV, Lithium Power has agreed to fund exploration and development costs with Li3 and MSB having a free carry until the completion of a definitive feasibility study.
Bearing Resources Ltd. (BRGRF), closed Tuesday's trading session at $0.7032, up 2.79%, on 11,990 volume with 9 trades. The average volume for the last 60 days is 29,292 and the stock's 52-week low/high is $0.3036/$1.4111.
Bollente Companies, Inc. (BOLC)
The QualityStocks Daily Newsletter would like to spotlight Bollente Companies, Inc. (BOLC). Today, Bollente Companies, Inc. closed trading at $0.80, up 14.29%, on 1,200 volume with 1 trade. The stock’s average daily volume over the past 60 days is 8,847 and its 52-week low/high is $0.20/$1.0041.
Bollente Companies, Inc. today announced that its trutankless line of smart water heaters has been chosen for both a retrofit project and new construction of townhomes at Friendship Village, a retirement community touted as "senior living for the young-at-heart," located in Tempe, Ariz. Developed in 1980 by The Weitz Company as one of the nation's first Continuing Care Retirement Communities, Friendship Village has undertaken an aggressive retrofit project to cut utility costs and extend the replacement cycle of water heating equipment by replacing traditional tank water heaters in its 300+ cottages with energy-efficient, space-saving tankless units. The project is expected to be completed in 2018 with the first phase of around 100 trutankless water heaters already installed.
Bollente Companies, Inc. (BOLC) is in the early stages of developing a diverse portfolio of companies, targeting disruptive technologies that positively impact the environment and emerging economies. Their current focus is on high-efficiency electric tankless water heaters, manufactured and sold under "trutankless", a division of Bollente, including a line of economy tankless water heaters sold under the Vero name. Units are available for both residential and commercial application.
The primary Bollente advantage is their use of advanced technology, superior to previous tankless systems, together with a growing U.S. and global market. Traditional water heaters are one of the costliest appliances to operate. The two primary energy sources used in U.S. homes are electric and natural gas, with less than half of U.S. homes having natural gas available. In addition, there are no significant electric whole home tankless manufacturers.
The U.S. Department of Energy now requires tanks of 55 gallons or more to have efficiency levels requiring expensive heat pumps to achieve. Bollente's trutankless electric tankless water heater employs specialized sensors for constant water temperature, solid state electronics, and proprietary software, resulting in one of the most efficient heat exchangers ever produced. The technology includes smart grid and home automation capabilities, remote control and monitoring, and even smartphone alerts. It also allows adjustable custom power management settings, so that users can further enhance energy usage and performance. It is now estimated that tankless heaters used in every home would save over $8 billion annually in the U.S. alone.
By maintaining 99 percent efficiency, Bollente's trutankless heaters use less energy than tank heaters, while providing the convenience of always-hot water. The system only uses power when there is demand, producing water to exact temperature, within one degree, even with sudden changes to input. Wireless apps allow for remote settings, notifications, and monitoring, and models are compatible with existing home automation and energy management systems. The technology also reduces size, for easy location, and the system's self-flushing design provides up to 20+ years of maintenance free operation, significantly reducing upkeep and replacement costs. This becomes an additional environmental benefit since roughly 8 million used water heaters are dumped in landfills every year.
Bollente has also announced the formation of Bollente International, Inc., a wholly-owned subsidiary, for the international production and sale of trutankless systems. Taking advantage of growing interest in their technology, Bollente International is working with an international manufacturing firm for the production and distribution of trutankless systems throughout Europe, Asia, Australia and New Zealand, with the first step being the testing and certification necessary to meet the various international standards.
Bollente has made electric tankless water heating compelling to a major consumer market, both in and outside the U.S., offering economic as well as operational efficiency and convenience, attractive to builders as well as to end consumers. Disclaimer
Bollente Companies, Inc. Blog
Bollente Companies, Inc. News:
Bollente Companies Increases Presence in Trending Segment of Commercial Construction with Its Smart trutankless Product Line
Award-Winning Luxury Builder Cullum Homes Makes trutankless® the Exclusive Water Heating Solution in its Communities
Bollente Companies, Inc. (BOLC) is “One to Watch”
ORHub, Inc. (ORHB)
The QualityStocks Daily Newsletter would like to spotlight ORHub, Inc. (ORHB). Today, ORHub, Inc. closed trading at $0.3998, up 8.05%, on 189,917 volume with 69 trades. The stock’s average daily volume over the past 60 days is 138,688 and its 52-week low/high is $0.05/$2.09.
ORHub, Inc. (ORHB) is a cloud-based software platform designed to transform the business of surgery into a value-based model. The platform empowers care providers at every stage of the surgical process to collaborate, organize, deliver, measure, and reimburse in one intuitive, easy-to-use program. This significantly decreases cost and improves outcomes by eliminating inefficiencies, duplications of effort, and errors and omissions that result from siloed processes in outdated software and poor handoffs from one part of the care process to another.
The need for ORHub is clear. Health care costs are out of control at more than 17% of US GDP, which equates to over $3 trillion per year. With costs rising every year due to an aging population and increasingly expensive treatments, providers are under severe pressure to become more efficient and reduce costs. This is happening because payors are aggressively reducing reimbursements and finally moving away from fee-for-service and toward a performance-based reimbursement system referred to as value-based health care.
Accurately measuring the cost of treating a condition and relating that cost to the patient's outcome is at the heart of value-based health care. Institutions that have adopted this model have reaped savings of 20-40% on their overall cost of care. Unfortunately, today's siloed IT systems are fundamentally at odds with this process. Legacy health care solutions come from a fee-for-service world and have reinforced the problem and produced a system with erratic quality and unsustainable costs. Most health care applications today are incremental improvements on these existing systems or are simple digital implementations of antiquated pen-and-paper processes.
Providers wanting to practice value-based health care need value-based software. ORHub creates a value-based solution that will revolutionize surgical care delivery by tracking the cost of treating a condition from diagnosis to discharge, and tracking outcomes that resulted from that treatment.
In an industry where major IT rollouts traditionally cost millions of dollars and take an average of eighteen months, pilot installations of ORHub have been completed in less than a month. By avoiding integration with legacy systems completely through a radically comprehensive and collaborative approach, providers see results right away. This approach produces real-time metrics in a uniform manner at any institution, which makes it ideal for large providers looking to make improvements across the board at multiple facilities.
ORHub started as a pilot program developed in cooperation with a major Southern California hospital. It has since expanded operations into a second facility at the number two non-profit hospital system in the US. Three additional pilot programs are scheduled prior to a national launch. The company has raised more than $1.6 million as of January 2017.
The company is also a showcase member of the startup program at Microsoft, which has been a key partner by providing financial assistance, strategy, introductions to influencers and mentors, and access to its sales organization who see ORHub as an exciting partner to expand the utilization of Microsoft Surface devices and Azure Cloud. Microsoft is funding a major case study in partnership with Intel about the impact of ORHub on participating institutions to be concluded sometime in Q2 2017.
ORHub's leadership team is helmed by Colt Melby, who was appointed CEO in 2016 and has been crucial to developing and executing the company's business strategy. Mr. Melby's extensive business experience includes the NASDAQ uplisting of Smith and Wesson (now American Outdoor Brands), CUI Global Inc., and Quest Resource Holdings Corp. His wealth of information and relationships have been vital in helping the company go from concept to production in institutional medicine in less than a year.
Delivering surgical care to a single patient is a complex process that may take half a dozen companies and more than a dozen departments cooperating inside and outside the care facility. ORHub simplifies and streamlines this process by enabling vendors, providers, and surgeons to collaborate on providing care. Disclaimer
ORHub, Inc. Blog
ORHub, Inc. News:
NetworkNewsWire Announces Publication on Solutions for the Health Care Industry's Data Processing Needs
NetworkNewsWire Announces Publication of Discussion on the Value of IT & Big Data Analytics for the Health Care Industry
NetworkNewsWire Releases Exclusive Audio Interview with ORHub, Inc. (ORHB)
Monaker Group, Inc. (MKGI)
The QualityStocks Daily Newsletter would like to spotlight Monaker Group, Inc. (MKGI). Today, Monaker Group, Inc. closed trading at $2.66, up 5.56%, on 900 volume with 2 trades. The stock’s average daily volume over the past 60 days is 7,240, and its 52-week low/high is $1.33/$4.35.
Monaker Group, Inc. (MKGI) is a technology driven travel company focused on leveraging resources to become a significant presence in the fastest growing sector of the $1.3 trillion travel and tourism market. The company's flagship brand, NextTrip.com, is the industry's first and only real-time booking engine that features alternative lodging (vacation home rentals, resort residences and unused timeshare inventory), as well as a full selection of airlines, hotels, cruises, rental cars, tours and concierge services. These features are combined into a single, easy-to-use platform that gives travelers complete real-time control when planning and booking their vacations.
NextTrip.com takes an integrated approach to the needs of travelers by combining multiple booking solutions into a highly intuitive real-time booking platform. Since its launch in February 2016, NextTrip has already grown to more than 250,000 units of vacation rental inventory. Monaker currently has roughly 1 million additional alternative lodging units under contract that will soon be added to the platform. This will place NextTrip among the top three largest vacation rental inventories and rival industry peers, Airbnb and HomeAway, in the rapidly expanding alternative lodging market. Unlike the competition, which book by request which can take hours or days before a lodging owner confirms, NextTrip's platform books in real-time, similar to online hotel bookings.
Most NextTrip listings are in desirable locations in the U.S., the EU and the Caribbean with about 20% exclusive listings. Monaker expects rapid exclusive listing growth because, unlike the competition, Monaker doesn't charge a sign-up fee, just a commission upon booking. The competition charges both. Monaker even has a proprietary solution to unlock Timeshare and Fractional Share properties as rental inventory.
Through strategic partnerships and acquisitions Monaker is now positioned to be a major player in the travel and alternative lodging sector. In addition Monaker is also the parent to Maupintour and Voyage TV.
In business for 65 years, Maupintour still leads the tour industry in the creation of outstanding, unique itineraries and has the highest repeat rate in the tour industry. Maupintour's upscale luxury services create a unique blend with the various product offerings of NextTrip. Voyage TV has thousands of hours of travel footage shot in over 30 countries worldwide. These 15,000 video clips of hotels, resorts, cruise, and destination activities are a treasure trove for vacation travel marketing.
With an established portfolio of travel brands, and a proven record acquiring, consolidating and integrating companies, Monaker is building a diverse and exciting foundation to drive the company's future. According to data from the U.S. Travel Association, direct spending on leisure travel by domestic and international travelers topped $650 billion in 2015. When combined with the fact that roughly 64 percent of travel companies are still considered small businesses, Monaker's all-inclusive approach to vacation booking through NextTrip and Maupintour strategically positions it for sustainable growth moving forward.
Monaker is headquartered in South Florida with offices in California. The company is led by a seasoned management team with decades of applicable industry experience. Monaker's Chairman and Chief Executive Officer Bill Kerby has over 18 years of experience in the media and travel industries, as well as 10 years of experience in the financial industry. Disclaimer
Monaker Group, Inc. Company Blog
Monaker Group, Inc. News:
Monaker Group to Present at the 29th Annual ROTH Conference, March 15, 2017
Monaker Group Appoints Robert Post to Board of Directors
Monaker Group Appoints Simon Orange to Board of Directors Appointment Advances Monaker's Plans for NASDAQ Listing
The QualityStocks Daily Newsletter would like to spotlight ChineseInvestors.com (CIIX). Today, ChineseInvestors.com closed trading at $1.28, up 2.40%, on 73,126 volume with 104 trades. The stock’s average daily volume over the past 60 days is 173,862 and its 52-week low/high is $0.12/$2.75.
Founded in 1999, ChineseInvestors.com (CIIX) has become a leading financial information website for Chinese-speaking investors in the United States and China. Recognizing unprecedented opportunities in the U.S. cannabis industry, CIIX is also laying the groundwork to capitalize on growing demand for cannabidiol (CBD)-based nutrition and health products.
Through its primary website, www.ChineseInvestors.com, CIIX offers a variety of investor education products and services, including real-time market commentary, analysis and educational related services in Chinese language character sets; consultative services to smaller private companies considering becoming a public company; and advertising and public relations related support services.
At the center of this initiative is the ChineseInvestors Method, a unique integration of a disciplined investing process, web-based tools, personalized instructions and support. Using this strategy, CIIX provides reliable market information to help investors make informed investment decisions and meet their individualized financial goals.
CIIX is also leveraging its financial expertise to enter into the burgeoning CBD industry, which within a few years has grown from a relatively invisible sector to a billowing market expected to reach $2.1 billion in consumer sales by 2020.
The increasing demand for CBD-based products is a catalyst for innovative business endeavors. To this accord, CIIX has established a three-year development plan to capitalize on the convergence of CBD and the nutrition and health products market in mainland China, where the benefits of CBD oil have not been widely recognized.
Under a wholesale agreement with a reputable CBD health brand, CIIX is launching the world's first online CBD health products store published in the Chinese language. The site, www.ChineseCBDoil.com, caters to a growing number of Chinese people awakening to the numerous health benefits of CBD oil for treatment of a variety of conditions such as anxiety, stress, poor sleep, Alzheimer's disease, and more. CIIX expects to launch this website at the end of January 2017, and plans to sell CBD-infused products via online and in-store.
In conjunction, CIIX's cannabis-focused "Yelp"-style mobile app is in development as a platform for Chinese people to review and discuss various cannabis products. The app will be the first marijuana social media mobile app designed for Chinese-speaking customers worldwide. Disclaimer
ChineseInvestors.com to Attend 'Invest 2017' Exhibition in Stuttgart, Germany
ChineseInvestors.com Announces Investment in Breakwater MB, LLC a Cannabis-Focused Investment and Consulting Company
Alan Klitenic, Director of Investor Relations for ChineseInvestors.com, Discusses Recent CIIX News and Industry Trends in a New Audio Interview with SmallCapVoice.com
InMed Pharmaceuticals, Inc. (IMLFF)
The QualityStocks Daily Newsletter would like to spotlight InMed Pharmaceuticals, Inc. (IMLFF). Today, InMed Pharmaceuticals, Inc. closed trading at $0.66, up 0.50%, on 1,535,587 volume with 866 trades. The stock’s average daily volume over the past 60 days is 1,108,929, and its 52-week low/high is $0.05/$0.72.
InMed Pharmaceuticals, Inc. (IMLFF) is a preclinical-stage biopharmaceutical company specializing in the development of novel therapeutics leveraging the pharmacological benefits of cannabinoids. Utilizing its proprietary bioinformatics assessment tool, InMed aims to identify bioactive compounds found within the cannabis plant that have the potential to offer optimized therapeutic benefit while demonstrating limited adverse effects. This assessment tool, in combination with the company’s cannabinoid biosynthesis technology and drug development pipeline, serves as InMed’s fundamental value driver.
Bioinformatics is a proprietary, computer-based program designed to assist in the identification of novel cannabinoids using comprehensive algorithms to integrate data from numerous bioinformatics databases, as well as a database on the structure of currently approved pharmaceutical products and an extensive database on over 90 individual cannabinoid drugs found in cannabis. This extensive collection of data is derived from both public and propriety-based sources. Leveraging this tool, the company aims to create associations between approved pharmaceuticals and cannabinoids with similar structures in order to identify active cannabinoids that have the potential to treat specific diseases. Per InMed’s website, this type of bioinformatics assessment represents “significant promise for future drug discovery, as it integrates many data sets and builds holistic models to approach a specific disease.”
After discovering these promising active cannabinoids, InMed moves to test and confirm their activity in biological systems through in vitro and in vivo experimentation. It is at this stage of development that the company’s proprietary biosynthesis process of cannabinoid manufacturing will be most promising. InMed is currently developing a robust, high-yield biosynthesis process for manufacturing all 90+ naturally-occurring cannabinoids. By modifying the agriculture-based formula for harvesting cannabinoids, InMed aims to combine the inherent safety and known efficacy of the natural drug structure with the convenience, control and quality of 21st Century laboratory-based manufacturing processes.
The company’s pipeline currently includes two drug candidates in preclinical development, including INM-750 for the treatment of epidermolysis bullosa (EB) and INM-085 for the treatment of glaucoma. Referred to by the Dystrophic Epidermolysis Bullosa Research Association of America as “The Worst Disease You’ve Never Heard Of,” EB is a rare genetic connective tissue disorder that affects roughly one out of every 20,000 births in the United States. The condition currently has no approved treatment or cure. Through the development of INM-750, InMed is attempting to address this significant unmet medical need. The drug candidate replaces missing keratins in the skin with specially selected cannabinoids in an effort to modulate the painful manifestations of EB.
INM-085, InMed’s second development candidate, is formulated to reduce the elevated intra-ocular pressure that is often associated with glaucoma. Additionally, the cannabinoids utilized in INM-085 are expected to provide neuroprotection for the retinal ganglion cells and other optic nerve tissues following topical administration. Although it is still in preclinical development, INM-085 targets a sizable market. According to the Glaucoma Research Foundation, glaucoma is a leading cause of blindness with no approved cure. The National Institutes of Health estimates that more than 3 million Americans currently have glaucoma, and more than 120,000 have been blinded by the disease.
InMed is focused on progressing toward validation of its drug candidate selection, using data to secure its patents and developing key disruptive technologies. In 2016, the company was successful in completing financings of $1.9 million. In January 2017, InMed completed a non-brokered private placement of common shares generating aggregate gross proceeds of C$1.5 million, strongly positioning the company to attract the new investment required to fund its aggressive growth strategies in 2017.
The company’s management team has well over a century of combined experience in the biopharmaceutical space. Company CEO Eric Adams has more than 25 years of experience in company and capital formation, global market development, mergers and acquisitions, licensing and corporate governance. During his time as CEO of enGene Inc., he led the gene therapy startup to a position at the head of the industry.
Joining Adams on the InMed management team are Chief Scientific Officer Dr. Sazzan Hossain; Senior Vice President, Clinical and Regulatory Affairs Alexandra D.J. Mancini; SVP, Corporate Strategy & Investor Relations Chris Bogart; and Chief Financial Officer Jeff Charpentier, as well as Chief Medical Officer Dr. Ado Muhammed, MD, DPM, MFPM.
Muhammed, in particular, has an extensive history in the pharmaceutical industry, having previously served as an executive of GW Pharmaceuticals, a global leader in the development of cannabinoid-based medicines. During his time as Associate Medical Director of that company, Muhammed played an instrumental role in the development and FDA approval of one of the first cannabis drugs. This GW Pharmaceuticals development program coincided with a sharp rise in share price from less than $9 in 2013 to more than $129 today, with the company’s current market value totaling more than $2.9 billion. Disclaimer
InMed Pharmaceuticals, Inc. Company Blog
InMed Pharmaceuticals, Inc. News:
InMed Pharmaceuticals' Unique Approach Featured in Forbes -- CFN Media
InMed's Exceptional Management Team Executes Ambitious Plan -- CFN Media
NetworkNewsWire Announces Publication of Discussion on the R&D of Cannabinoids for Medical Use
Today's Top 3
The QualityStocks Public Company Sponsor News
- Get profiles for new featured companies at clients.qualitystocks.net
- Bollente Companies, Inc. (BOLC) Award-Winning Luxury Builder Cullum Homes Makes trutankless® the Exclusive Water Heating Solution in its Communities
- CD International Enterprises, Inc. (CDII) Announces Engagement of QualityStocks Corporate Communications Suite
- ChineseInvestors.com, Inc. (CIIX) to Attend 'Invest 2017' Exhibition in Stuttgart, Germany
- Dominovas Energy Corp. (DNRG) Obtains Partner to Facilitate Financing, Development and Production for RUBICON(TM) Fuel Cell Systems
- eXp World Holdings, Inc. (EXPI) to Present at The MicroCap Conference on April 4th in New York
- Grey Cloak Tech, Inc. (GRCK) is “One to Watch”
- GreenStone Healthcare Corp. (GRST) Buys Canadian Real Estate Assets, Sells Canadian Addiction Treatment Business, and Acquires Addiction Treatment Business in Florida
- India Globalization Capital, Inc. (NYSE: IGC) Files International Patents for IGC-501 Compound Indicated for Neuropathic Pain
- InMed Pharmaceuticals Inc. (IMLFF) Unique Approach Featured in Forbes -- CFN Media
- MGX Minerals Inc. (MGXMF) Announces Unitization of Oil and Gas Leases and Addition of 70,000 Acres Overlying Lithium Brine Claims at Paradox Basin Utah
- Monaker Group, Inc. (MKGI) to Present at the 29th Annual ROTH Conference, March 15, 2017
- National Waste Management Holdings, Inc. (NWMH) Expands Territory with Acquisition of Burts Refuse, LLC
- One Step Vending Corp. (KOSK) Installs Four New Micro Markets at a San Diego Pharmaceutical Facility
- ORHub, Inc. (ORHB) NetworkNewsWire Announces Publication on Solutions for the Health Care Industry's Data Processing Needs
- ProBility Media Corp. (PBYA) Appoints Billy Smith to the Newly Created Vocational Advisory Board
- Players Network (OTCQB: PNTV) CEO Provides 1Q Shareholder Update, Outlook
- Singlepoint, Inc. (SING) NetworkNewsWire Announces Publication Highlighting Several Investment Options in the Marijuana Market
- Stealth Technologies, Inc. (STTH) Announces 5 New Products